DAS181, A Novel Sialidase Fusion Protein, Protects Mice from Lethal Avian Influenza H5N1 Virus Infection
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (10) , 1493-1499
- https://doi.org/10.1086/522609
Abstract
Increasing resistance to currently available influenza antivirals highlights the need to develop alternate approaches for the prevention and/or treatKeywords
This publication has 22 references indexed in Scilit:
- Rimantadine Hydrochloride and Amantadine Hydrochloride Use in Influenza A Virus InfectionsPublished by Elsevier ,2021
- Three Indonesian Clusters of H5N1 Virus Infection in 2005New England Journal of Medicine, 2006
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNature Medicine, 2006
- Oseltamivir Resistance during Treatment of Influenza A (H5N1) InfectionNew England Journal of Medicine, 2005
- Isolation of drug-resistant H5N1 virusNature, 2005
- Confronting the avian influenza threat: vaccine development for a potential pandemicThe Lancet Infectious Diseases, 2004
- Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutininJournal of Medical Virology, 2003
- The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza virusesAntiviral Research, 2000
- Influenza virus neuraminidase inhibitorsThe Lancet, 2000
- Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitorAntiviral Research, 1998